Arrowhead Research | ARWR - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q2 Mar/2026 -0.93 -1.04 2.75 May/07
FY2026Q1 Dec/2025 0.22 0.04 -1.39 Feb/05
FY2025Q4 Sep/2025 -0.11 -0.23 -1.36 Nov/25
FY2025Q3 Jun/2025 -1.26 -0.86 -1.38 Aug/07
FY2025Q2 Mar/2025 2.75 -0.11 -1.02 May/12




Eps Cambiamento Data
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD -0.93 1.15 2026-03
Heron Therapeutics USD -0.02 0.02 2025-12
Incyte USD 1.81 0.01 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Ligand Pharmaceuticals USD 1.63 0.39 2026-03
Merck USD -1.28 3.32 2026-03
Moderna USD -3.4 1.29 2026-03
Nektar Therapeutics USD -1.35 1.17 2025-12
Novartis USD 1.99 0.04 2026-03
Sarepta Therapeutics USD 3.16 6.74 2026-03
TG Therapeutics USD 0.12 0.02 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03
Xencor USD -1.71 1.62 2026-03